News from Accelovance A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Dec 02, 2015, 12:17 ET Accelovance, Inc. élargit son empreinte géographique et son offre de services avec l'acquisition de Clinquest, Inc. & BV

Accelovance, Inc. (Accelovance), société internationale de recherche sous contrat (CRO) spécialisée dans la recherche clinique...


Dec 02, 2015, 09:08 ET Accelovance, Inc. setzt mit Übernahme von Clinquest, Inc. und BV seine Expansion in weitere Regionen fort und dehnt auch den Service weiter aus

Accelovance, Inc. (Accelovance), ein global tätiges Auftragsforschungsinstitut (Contract Research Organization, CRO) mit Schwerpunktsetzung...


Dec 02, 2015, 04:25 ET Accelovance, Inc. sigue con su expansión geográfica y de servicio con la adquisición de Clinquest, Inc. & BV

Accelovance, Inc. (Accelovance), una organización de investigación contractual (CRO) centrada en las áreas de oncología,...


Dec 02, 2015, 02:00 ET Accelovance, Inc. Continues Geographic and Service Expansion with Acquisition of Clinquest, Inc. & BV

 Accelovance, Inc. (Accelovance), a global contract research organization (CRO) focusing in oncology, vaccines, and general medicine clinical...


Nov 03, 2015, 06:52 ET Accelovance, Inc. y FHI 360 mejoran su oferta de servicio mediante una alianza estratégica internacional

 Accelovance, Inc. (Accelovance), una organización de investigación contractual (CRO) centrada en las áreas de oncología,...


Nov 03, 2015, 06:44 ET Accelovance, Inc. et FHI 360 optimisent leurs offres de service grâce à une alliance stratégique internationale

 Accelovance, Inc. (Accelovance), un organisme international de recherche sous contrat (ORC) axé sur l'oncologie, les vaccins et la...


Nov 03, 2015, 02:00 ET Accelovance, Inc. und FHI 360 erweitern mit internationaler strategischer Allianz ihr Leistungsangebot

 Accelovance, Inc. (Accelovance), ein global tätiges Auftragsforschungsinstitut (Contract Research Organization, CRO) mit...


Nov 03, 2015, 02:00 ET Accelovance, Inc. and FHI 360 Enhance Service Offering Through International Strategic Alliance

 Accelovance, Inc. (Accelovance), a global contract research organization (CRO) focusing in Oncology, Vaccines, and General Medicine and FHI...


Sep 30, 2015, 07:00 ET Accelovance Continues Oncology Leadership Growth with Addition of Former Global VP, Oncology from Wyeth/Pfizer and Bayer

 Accelovance, Inc. (Accelovance), a contract research organization (CRO) focusing in oncology, vaccines, and general medicine, today announced...


Sep 16, 2015, 04:51 ET Midwest Melanoma Partnership y Accelovance, Inc. mejoran la oferta de investigación del melanoma

Accelovance, Inc. (Accelovance), una organización de investigación contractual global (CRO) centrada en la oncología, vacunas y...


Sep 15, 2015, 12:56 ET Le Midwest Melanoma Partnership et Accelovance, Inc. enrichissent l'offre de recherche autour du mélanome via la conclusion d'une alliance stratégique

Accelovance, Inc. (Accelovance), société internationale de recherche sous contrat (CRO) spécialisée en oncologie, vaccins et...


Sep 15, 2015, 02:00 ET Midwest Melanoma Partnership and Accelovance, Inc. Enhance Melanoma Research Offering Through Strategic Alliance

Accelovance, Inc. (Accelovance), a global contract research organization (CRO) focusing in oncology, vaccines, and general medicine and the Midwest...


Feb 05, 2015, 12:00 ET Accelovance expande sus capacidades en Europa con la adquisición de Altair Clinical, Ltd.

Accelovance, Inc. (Accelovance), una organización de investigación contractual (CRO) alineada terapéuticamente en las áreas de...


Feb 05, 2015, 08:52 ET Accelovance accroît ses capacités en Europe avec l'acquisition d'Altair Clinical, Ltd.

Accelovance, Inc. (Accelovance), une société de recherche sous contrat (CRO) alignée d'un point de vue thérapeutique dans les...


Feb 05, 2015, 07:51 ET Accelovance erweitert Kapazitäten in Europa mit der Übernahme von Altair Clinical, Ltd.

Accelovance, Inc. (Accelovance), ein therapeutisch orientiertes Auftragsforschungsinstitut (Contract Research Organization / CRO) in den Bereichen...


Feb 05, 2015, 03:00 ET Accelovance Expands Capabilities in Europe with Acquisition of Altair Clinical, Ltd.

Accelovance, Inc. (Accelovance), a Contract Research Organization (CRO) therapeutically aligned in the areas of Oncology, Vaccines, and General...


Sep 30, 2014, 07:00 ET Former VP, Oncology, from Pfizer and Otsuka Joins Accelovance to Augment Oncology Growth

 Accelovance, Inc. (Accelovance), a contract research organization (CRO) focusing in early phase oncology, vaccines, and general medicine,...


Feb 19, 2014, 16:45 ET Accelovance Continues Expansion with Opening of Research Triangle Park, North Carolina Office

Accelovance, a therapeutically focused clinical research organization (CRO), announced today the opening of a new office in Research Triangle Park...


Jul 10, 2013, 11:18 ET Accelovance Primed to Achieve Leadership in Oncology Clinical Trials

"Oncology Protocol Challenge" and New Appointments Underscore Commitment to Cancer Studies  This spring has seen Accelovance, a Rockville,...


Mar 26, 2013, 10:49 ET Sixth Consecutive "Best CRO" Award Nomination for Accelovance

 Accelovance, Inc., a Maryland based contract research organization (CRO), was nominated for the 2013 ViE "Best CRO" Award for the sixth year...


Mar 06, 2013, 14:48 ET Accelovance Expansion Continues with Acquisition of Radiant Development, the CRO Division of Radiant Research

 Accelovance, Inc. announced today the acquisition of Radiant Development, the CRO division of Radiant Research. This is the latest development...


Mar 01, 2013, 11:18 ET Accelovance Expands Oncology Leadership with the Addition of Ralph Boccia, MD as Oncology Medical Director

 Accelovance announces the addition of Ralph Boccia, MD, FACP as the Oncology Medical Director.  The addition of Dr. Boccia is a strong...


Nov 14, 2011, 11:07 ET Accelovance Strengthens Executive Team with Chief Medical Officer

 Accelovance, an award-winning clinical services company, announced today the addition of Stephan A. Bart Sr., M.D. as Chief Medical Officer...


Apr 18, 2011, 14:18 ET Continued Recognition for Excellence; Accelovance Named 2011 "Best CRO"

Accelovance, a privately held clinical research company has been named the "Best Contract Research Organization (CRO)" for a third consecutive...


Apr 27, 2010, 10:22 ET Accelovance Named 2010 BEST CRO; Repeat Recognition for Vaccine Excellence

Accelovance, a privately held vaccine-focused clinical research company, enthusiastically announced today that it has been named the "Best Contract...